Form 8-K - Current report:
SEC Accession No. 0001193125-17-347025
Filing Date
2017-11-17
Accepted
2017-11-17 16:46:56
Documents
6
Period of Report
2017-11-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d465134d8k.htm 8-K 17955
2 EX-10.1 d465134dex101.htm EX-10.1 602137
3 GRAPHIC g465134g1116130041571.jpg GRAPHIC 21911
4 GRAPHIC g465134g1116130042055.jpg GRAPHIC 37074
5 GRAPHIC g465134g1116130042605.jpg GRAPHIC 95216
6 GRAPHIC g465134g22m20.jpg GRAPHIC 56306
  Complete submission text file 0001193125-17-347025.txt   911758
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 171211592
SIC: 2834 Pharmaceutical Preparations